期刊文献+

1型神经纤维瘤病相关脊柱畸形致病机制的研究进展 被引量:2

RESEARCH PROGRESS OF PATHOGENESIS MECHANISM OF SPINAL DEFORMITY IN NEUROFIBROMATOSIS TYPE 1
原文传递
导出
摘要 目的综述1型神经纤维瘤病(neurofibromatosis type 1,NF1)相关的脊柱畸形致病机制研究进展。方法广泛查阅近年国内外有关NF1相关脊柱畸形致病机制的文献,对其与脊柱畸形的相互联系、相关致病机制及研究进展进行综述。结果目前对于NF1患者发生脊柱畸形的致病机制尚未明确,可能与神经纤维瘤直接侵蚀与压迫、椎管内硬脊膜扩张、褪黑素导致的脊柱旁肌肉收缩力下降、骨量减少与骨质疏松、性早熟以及中胚层发育不良有关。结论 NF1患者的众多临床表现可能是导致其脊柱畸形发生的诱因,NF1相关脊柱畸形致病机制的研究将有助于对NF1脊柱畸形的认识、诊断和治疗。 Objective To review the research progress of pathogenesis mechanism of spinal deformity in neurofibromatosis type 1(NF1). Methods Recent literature concerning the pathogenesis mechanism of spinal deformity in NF1 was extensively reviewed, and current developments of the correction of spinal deformity and NF1 and the pathogenesis mechanism were summarized. Results The pathogenesis mechanism of spinal deformity in NF1 is not yet clearly known. Current theories include erosion and stress of neurofibromas, melatonin-related decreased contractility of paraspinal muscles, osteopenia and osteoporosis, sexual precocity and mesoderm dysplasia. Conclusion The clinical manifestations of NF1 may cause the spinal deformities in patients with NF1. The research of pathogenesis mechanism of spinal deformity in NF1 will be conducive to further understanding, diagnosis and treatment of NF1-related spinal deformity.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2016年第9期1174-1178,共5页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(81401760)~~
关键词 1型神经纤维瘤病 脊柱畸形 致病机制 Neurofibromatosis type 1 Spinal deformity Pathogenesis mechanism
  • 相关文献

参考文献50

  • 1Zhou Y, He Y, Sharma R, et al. Hyperactive RAS/PI3-K/ MAPK Signaling Cascade in Migration and Adhesion of Nfl Haploinsufi'icient Mesenchymal Stem/Progenitor Cells. Int J Mol Sci, 2015, 16(6): 12345-12359.
  • 2Upadhyaya M, Huson SM, Davies M, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NFI gene (c.2970-2972 delAAT): evidence of a clinically significant NFI genotype-phenotype correlation. Am J Hum Genet, 2007, 80(1): 140-151.
  • 3Abdel-Wanis ME, Kawahara N. Aetiology of spinal deformities inneurofibromatosis 1: new hypotheses. Med Hypotheses, 2001, 56(3): 400-404.
  • 4Tsirikos AI, Saifuddin A, Noordeen MH. Spinal deformity in neurofibromatosis type-l: diagnosis and treatment. Eur Spine J, 2005, 14(5): 427-439.
  • 5Guha A, Lau N, Huvar I, et al. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene, 1996, 12(3): 507-513.
  • 6Cho SK, Stoker GE, Bridwell KH. Spinal reconstruction with pedicle screw-based instrumentation and rhBMP-2 in patients with neurofibromatosis and severe dural ectasia and spinal deformity: report of two cases and a review of the literature.JBone Joint Surg (Am), 2011, 93(15): e86.
  • 7Fares Y, Haddad GF, Khazim R, et al. Vertebral scalloping in neurofibromatosis- 1. Neurosciences (Riyadh), 2007, 12(2): 155-157.
  • 8Casselman ES, Mandell GA. Vertebral scalloping in neurofibromatosis. Radiology, 1979, 131( 1 ): 89-94.
  • 9Lim C, Kwon K, Lee K. Plexiform neurofibroma treated with pharmacopuncture.JPharrnacopuncture, 2014, 17(3): 74-77.
  • 10Rutkowski JL, Wu K, Gutmann DH, et al. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet, 2000, 9(7): 1059-1066.

二级参考文献4

同被引文献4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部